Citations (64)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (9)
Ji Taek Hong. (2021) Current Opinion on Prucalopride in Gastroparesis and Chronic Constipation Treatment: A Focus on Patient Selection and Safety. Therapeutics and Clinical Risk Management 17, pages 601-615.
Read now
Read now
Jeffery Johns, Klaus Krogh, Gianna M. Rodriguez, Janice Eng, Emily Haller, Malorie Heinen, Rafferty Laredo, Walter Longo, Wilda Montero-Colon, Catherine S. Wilson & Mark Korsten. (2021) Management of Neurogenic Bowel Dysfunction in Adults after Spinal Cord Injury. The Journal of Spinal Cord Medicine 44:3, pages 442-510.
Read now
Read now
Priya Vijayvargiya & Michael Camilleri. (2019) Use of prucalopride in adults with chronic idiopathic constipation. Expert Review of Clinical Pharmacology 12:7, pages 579-589.
Read now
Read now
Kay Diederen, Suzanne Marian Mugie & Marc Alexander Benninga. (2015) Efficacy and safety of prucalopride in adults and children with chronic constipation. Expert Opinion on Pharmacotherapy 16:3, pages 407-416.
Read now
Read now
Maura Corsetti & Jan Tack. (2014) New pharmacological treatment options for chronic constipation. Expert Opinion on Pharmacotherapy 15:7, pages 927-941.
Read now
Read now
Jan Tack & Maura Corsetti. (2012) Prucalopride: evaluation of the pharmacokinetics, pharmacodynamics, efficacy and safety in the treatment of chronic constipation. Expert Opinion on Drug Metabolism & Toxicology 8:10, pages 1327-1335.
Read now
Read now
Banny S Wong, Noriaki Manabe & Michael Camilleri. (2010) Role of prucalopride, a serotonin (5-HT4) receptor agonist, for the treatment of chronic constipation. Clinical and Experimental Gastroenterology 3, pages 49-56.
Read now
Read now
Michael Camilleri & Annemie Deiteren. (2010) Prucalopride for constipation. Expert Opinion on Pharmacotherapy 11:3, pages 451-461.
Read now
Read now
Jan Tack. (2009) Prucalopride: a new drug for the treatment of chronic constipation. Expert Review of Gastroenterology & Hepatology 3:4, pages 337-343.
Read now
Read now
Articles from other publishers (55)
Serhat Bor, İsmail H. Kalkan, Edoardo Savarino, Satish Rao, Jan Tack, Jay Pasricha, David Cangemi, Jolien Schol, Tennekon Karunaratne, Matteo Ghisa, Nitin K. Ahuja & Brian Lacy. (2024) Prokinetics‐safety and efficacy: The European Society of Neurogastroenterology and Motility/The American Neurogastroenterology and Motility Society expert review. Neurogastroenterology & Motility 36:5.
Crossref
Crossref
Fredrika Magnuson, Peter Christensen, Andrei Krassioukov, Gianna Rodriguez, Anton Emmanuel, Steven Kirshblum & Klaus Krogh. (2023) Neurogenic Bowel Dysfunction in Patients with Spinal Cord Injury and Multiple Sclerosis—An Updated and Simplified Treatment Algorithm. Journal of Clinical Medicine 12:22, pages 6971.
Crossref
Crossref
Chloë Lefèvre, Camille Le Roy, Anne Bessard, Catherine Le Berre-Scoul, Justine Marchix, Emmanuel Coron, Marc Le Rhun, Charlène Brochard, Brigitte Perrouin-Verbe & Michel Neunlist. (2023) Region-specific remodeling of the enteric nervous system and enteroendocrine cells in the colon of spinal cord injury patients. Scientific Reports 13:1.
Crossref
Crossref
Young Sin Cho, Yoo Jin Lee, Jeong Eun Shin, Hye-Kyung Jung, Seon-Young Park, Seung Joo Kang, Kyung Ho Song, Jung-Wook Kim, Hyun Chul Lim, Hee Sun Park, Seong-Jung Kim, Ra Ri Cha, Ki Bae Bang, Chang Seok Bang, Sung Kyun Yim, Seung-Bum Ryoo, Bong Hyeon Kye, Woong Bae Ji, Miyoung Choi, In-Kyung Sung & Suck Chei Choi. (2023) 2022 Seoul Consensus on Clinical Practice Guidelines for Functional Constipation. Journal of Neurogastroenterology and Motility 29:3, pages 271-305.
Crossref
Crossref
Hyun-Yoon KoHyun-Yoon Ko. 2023. A Practical Guide to Care of Spinal Cord Injuries. A Practical Guide to Care of Spinal Cord Injuries
135
179
.
V. Andresen, G. Becker, T. Frieling, M. Goebel-Stengel, F. Gundling, A. Herold, M. Karaus, J. Keller, M. Kim, P. Klose, H. Krammer, M. E. Kreis, R. Kuhlbusch-Zicklam, J. Langhorst, P. Layer, R. Lenzen-Großimlinghaus, A. Madisch, H. Mönnikes, S. Müller-Lissner, D. Rubin, M. Schemann, J. Schwille-Kiuntke, A. Stengel, M. Storr, I. van der Voort, W. Voderholzer, T. Wedel, S. Wirz, H. Witzigmann & C. Pehl. (2022) Aktualisierte S2k-Leitlinie chronische Obstipation der Deutschen Gesellschaft für Gastroenterologie, Verdauungs- und Stoffwechselkrankheiten (DGVS) und der Deutschen Gesellschaft für Neurogastroenterologie & Motilität (DGNM) – April 2022 – AWMF-Registriernummer: 021–019. Zeitschrift für Gastroenterologie 60:10, pages 1528-1572.
Crossref
Crossref
Seifeldin Hakim, Tanmay Gaglani & Brooks D. Cash. (2022) Neurogenic Bowel Dysfunction. Gastroenterology Clinics of North America 51:1, pages 93-105.
Crossref
Crossref
María Elena Ferreiro-Velasco, Antonio Montoto-Marqués, Mª Eugenia Díaz-Recarey, Renato Vilas-Boas, Sebastian Salvador-De La Barrera & Antonio Rodríguez-Sotillo. 2022. Diagnosis and Treatment of Spinal Cord Injury. Diagnosis and Treatment of Spinal Cord Injury
259
272
.
Steven R. Flanagan, Cynthia Hung, Robert Petrucelli & Mark Ragucci. 2022. Spasticity and Muscle Stiffness. Spasticity and Muscle Stiffness
169
191
.
William A. Bauman, Anton Sabiev, Shahzad Shallwani, Ann M. Spungen, Christopher M. Cirnigliaro & Mark A. Korsten. (2021) The Addition of Transdermal Delivery of Neostigmine and Glycopyrrolate by Iontophoresis to Thrice Weekly Bowel Care in Persons with Spinal Cord Injury: A Pilot Study. Journal of Clinical Medicine 10:5, pages 1135.
Crossref
Crossref
Jeffery Johns, Klaus Krogh, Gianna M. Rodriguez, Janice Eng, Emily Haller, Malorie Heinen, Rafferty Laredo, Walter Longo, Wilda Montero-Colon, Catherine Wilson & Mark Korsten. (2021) Management of Neurogenic Bowel Dysfunction in Adults after Spinal Cord Injury. Topics in Spinal Cord Injury Rehabilitation 27:2, pages 75-151.
Crossref
Crossref
Jeffery S Johns, Klaus Krogh, Karen Ethans, Joanne Chi, Matthew Querée & Janice J Eng. (2021) Pharmacological Management of Neurogenic Bowel Dysfunction after Spinal Cord Injury and Multiple Sclerosis: A Systematic Review and Clinical Implications. Journal of Clinical Medicine 10:4, pages 882.
Crossref
Crossref
Stefania MUSCO, Gabriele BAZZOCCHI, Jacopo MARTELLUCCI, Maria P. AMATO, Alberto MANASSERO, Daria PUTIGNANO, Stefania LOPATRIELLO, Davide CAFIERO, Francesca PAOLONI & Giulio DEL POPOLO. (2021) Treatments in neurogenic bowel dysfunctions: evidence reviews and clinical recommendations in adults. European Journal of Physical and Rehabilitation Medicine 56:6.
Crossref
Crossref
Gabriele Bazzocchi, Mimosa Balloni, Erica Poletti, Roberta Manara, Paola Mongardi, Marica Vicchi, Eugenia Fragalà, Elena Demertzis, Antonella Manzan & Humberto Cerrel Bazo. 2020. Suprapontine Lesions and Neurogenic Pelvic Dysfunctions. Suprapontine Lesions and Neurogenic Pelvic Dysfunctions
71
80
.
Gregory M. Holmes & Emily N. Blanke. (2019) Gastrointestinal dysfunction after spinal cord injury. Experimental Neurology 320, pages 113009.
Crossref
Crossref
Anton Emmanuel. 2018. Neurorehabilitation Therapy and Therapeutics. Neurorehabilitation Therapy and Therapeutics
218
223
.
Zhengyan Qi, James W Middleton & Allison Malcolm. (2018) Bowel Dysfunction in Spinal Cord Injury. Current Gastroenterology Reports 20:10.
Crossref
Crossref
Brid Callaghan, John B. Furness & Ruslan V. Pustovit. (2017) Neural pathways for colorectal control, relevance to spinal cord injury and treatment: a narrative review. Spinal Cord 56:3, pages 199-205.
Crossref
Crossref
David O. Prichard & Adil E. Bharucha. (2018) Recent advances in understanding and managing chronic constipation. F1000Research 7, pages 1640.
Crossref
Crossref
Herjan van der Steeg, André J. A. Bremers & Ivo de Blaauw. 2018. Neuro-Urology. Neuro-Urology
285
310
.
Anam Omer & Eamonn M.M. Quigley. (2017) An update on prucalopride in the treatment of chronic constipation. Therapeutic Advances in Gastroenterology 10:11, pages 877-887.
Crossref
Crossref
K Krogh, A Emmanuel, B Perrouin-Verbe, M A Korsten, M J Mulcahey & F Biering-Sørensen. (2017) International spinal cord injury bowel function basic data set (Version 2.0). Spinal Cord 55:7, pages 692-698.
Crossref
Crossref
K Krogh, G Chiarioni & W Whitehead. (2017) Management of chronic constipation in adults. United European Gastroenterology Journal 5:4, pages 465-472.
Crossref
Crossref
S D Nielsen, P M Faaborg, P Christensen, K Krogh & N B Finnerup. (2016) Chronic abdominal pain in long-term spinal cord injury: a follow-up study. Spinal Cord 55:3, pages 290-293.
Crossref
Crossref
Laura Martinez, Leila Neshatian & Rose Khavari. (2016) Neurogenic Bowel Dysfunction in Patients with Neurogenic Bladder. Current Bladder Dysfunction Reports 11:4, pages 334-340.
Crossref
Crossref
M. Bellini, D. Gambaccini & G. Bassotti. (2016) Prucalopride: For functional constipation only?. Techniques in Coloproctology 20:7, pages 433-436.
Crossref
Crossref
Muhammad S Sajid, Madhu Hebbar, Mirza K Baig, Andy Li & Zinu Philipose. (2016) Use of Prucalopride for Chronic Constipation: A Systematic Review and Meta-analysis of Published Randomized, Controlled Trials. Journal of Neurogastroenterology and Motility 22:3, pages 412-422.
Crossref
Crossref
P. K. Dhruva Rao, M. Lewis, S. P. M. Peiris, P. R. Shah & P. N. Haray. (2015) Long‐term outcome of prucalopride for chronic constipation: a single‐centre study. Colorectal Disease 17:12, pages 1079-1084.
Crossref
Crossref
Mellar Davis & Pamela Gamier. (2015) New Options in Constipation Management. Current Oncology Reports 17:12.
Crossref
Crossref
A G Ellis, P T Zeglinski, D J Brown, A G Frauman, M Millard & J B Furness. (2014) Pharmacokinetics of the ghrelin agonist capromorelin in a single ascending dose Phase-I safety trial in spinal cord-injured and able-bodied volunteers. Spinal Cord 53:2, pages 103-108.
Crossref
Crossref
E. N. Platoshkin & S. A. Shut. (2014) CONSTIPATION (REPORT 2: TREATMENT) (literature review). Health and Ecology Issues:2, pages 21-25.
Crossref
Crossref
Anton Emmanuel, Marina Cools, Lieve Vandeplassche & René Kerstens. (2014) Prucalopride Improves Bowel Function and Colonic Transit Time in Patients With Chronic Constipation: An Integrated Analysis. American Journal of Gastroenterology 109:6, pages 887-894.
Crossref
Crossref
Maureen Coggrave, Christine Norton & June D Cody. (2014) Management of faecal incontinence and constipation in adults with central neurological diseases. Cochrane Database of Systematic Reviews 2014:1.
Crossref
Crossref
Vithika Sivabalasundaram. (2014) Prucalopride-associated acute tubular necrosis. World Journal of Clinical Cases 2:8, pages 380.
Crossref
Crossref
Maureen Coggrave & Christine Norton. 1996. Cochrane Database of Systematic Reviews. Cochrane Database of Systematic Reviews.
Boaz Mendzelevski, Jannie Ausma, Dennis O. Chanter, Patricia Robinson, Rene Kerstens, Lieve Vandeplassche & John Camm. (2012) Assessment of the cardiac safety of prucalopride in healthy volunteers: a randomized, double‐blind, placebo‐ and positive‐controlled thorough QT study. British Journal of Clinical Pharmacology 73:2, pages 203-209.
Crossref
Crossref
Kevin K.-C. Liu, Subas M. Sakya, Christopher J. O’Donnell, Andrew C. Flick & Hong X. Ding. (2012) Synthetic approaches to the 2010 new drugs. Bioorganic & Medicinal Chemistry 20:3, pages 1155-1174.
Crossref
Crossref
Eamonn M. M. Quigley. (2011) Prucalopride: safety, efficacy and potential applications. Therapeutic Advances in Gastroenterology 5:1, pages 23-30.
Crossref
Crossref
Christian Pehl. (2012) Sekundäre Form der Obstipation aufgrund von medikamentösen Nebenwirkungen und endokrinen, neurologischen und psychiatrischen Erkrankungen medikamentös-konservative Therapieoptionen. Viszeralmedizin 28:4, pages 2-2.
Crossref
Crossref
P M Faaborg, P Christensen, M Rosenkilde, S Laurberg & K Krogh. (2010) Do gastrointestinal transit times and colonic dimensions change with time since spinal cord injury?. Spinal Cord 49:4, pages 549-553.
Crossref
Crossref
Klaus Krogh. 2010. Pelvic Organ Dysfunction in Neurological Disease. Pelvic Organ Dysfunction in Neurological Disease
127
137
.
. 2010. Pelvic Organ Dysfunction in Neurological Disease. Pelvic Organ Dysfunction in Neurological Disease
61
166
.
A Krassioukov, J J Eng, G Claxton, B M Sakakibara & S Shum. (2010) Neurogenic bowel management after spinal cord injury: a systematic review of the evidence. Spinal Cord 48:10, pages 718-733.
Crossref
Crossref
Gareth J. SangerEamonn M.M. Quigley. (2017)
Constipation, IBs and the 5-HT
4
Receptor: What Role for Prucalopride?
. Clinical Medicine. Gastroenterology 3, pages CGast.S4136.
Crossref
Crossref
E. M. M. QUIGLEY, L. VANDEPLASSCHE, R. KERSTENS & J. AUSMA. (2008) Clinical trial: the efficacy, impact on quality of life, and safety and tolerability of prucalopride in severe chronic constipation – a 12‐week, randomized, double‐blind, placebo‐controlled study. Alimentary Pharmacology & Therapeutics 29:3, pages 315-328.
Crossref
Crossref
S Media, P Christensen, I Lauge, M Al-Hashimi, S Laurberg & K Krogh. (2008) Reproducibility and validity of radiographically determined gastrointestinal and segmental colonic transit times in spinal cord-injured patients. Spinal Cord 47:1, pages 72-75.
Crossref
Crossref
Michael Camilleri, René Kerstens, An Rykx & Lieve Vandeplassche. (2008) A Placebo-Controlled Trial of Prucalopride for Severe Chronic Constipation. New England Journal of Medicine 358:22, pages 2344-2354.
Crossref
Crossref
J C Furlan, D R Urbach & M G Fehlings. (2007) Optimal treatment for severe neurogenic bowel dysfunction after chronic spinal cord injury: a decision analysis. British Journal of Surgery 94:9, pages 1139-1150.
Crossref
Crossref
K Krogh, P Christensen, S Sabroe & S Laurberg. (2005) Neurogenic bowel dysfunction score. Spinal Cord 44:10, pages 625-631.
Crossref
Crossref
Maureen Coggrave, Paul Wiesel & Christine C Norton. 1996. Cochrane Database of Systematic Reviews. Cochrane Database of Systematic Reviews.
Marca L. Sipski & J Scott Richards. (2006) Spinal Cord Injury Rehabilitation. American Journal of Physical Medicine & Rehabilitation 85:4, pages 310-342.
Crossref
Crossref
Robert H. DworkinJennifer KatzMichael J. Gitlin. (2005) Placebo response in clinical trials of depression and its implications for research on chronic neuropathic pain. Neurology 65:12_suppl_4.
Crossref
Crossref
Davide Pau, Antony J. Workman, Kathleen A. Kane & Andrew C. Rankin. (2005) Electrophysiological Effects of Prucalopride, a Novel Enterokinetic Agent, on Isolated Atrial Myocytes from Patients Treated with β-Adrenoceptor Antagonists. Journal of Pharmacology and Experimental Therapeutics 313:1, pages 146-153.
Crossref
Crossref
William L Hasler. (2003) Pharmacotherapy for intestinal motor and sensory disorders. Gastroenterology Clinics of North America 32:2, pages 707-732.
Crossref
Crossref
Hui-Bin Qi. (2003) Effect of enterokinetic prucalopride on intestinal motility in fast rats. World Journal of Gastroenterology 9:9, pages 2065.
Crossref
Crossref